New review puts horses in the antimicrobial resistance spotlight: full analysis
Version 2
A newly published review is putting horses more squarely into the antimicrobial resistance discussion. In Journal of Applied Genetics, Aleksandra Lepianka and Izabela Sitkiewicz describe horses, now often classified within the companion animal space, as potential reservoirs of commensal and pathogenic bacteria carrying antimicrobial resistance traits, with implications for both veterinary and public health. The open-access paper was published April 29, 2026. (link.springer.com)
The article arrives amid growing concern that companion animals have been undercounted in One Health antimicrobial resistance strategies. While dogs and cats tend to dominate that conversation, the authors argue that horses deserve more scrutiny because of their close contact with people, movement between facilities, and exposure to dense management environments such as breeding farms, training yards, and competition venues. Their review emphasizes that antibiotic pressure can reshape equine microbiota and select for resistant strains that may then circulate through direct contact or environmental routes. (link.springer.com)
The paper is a narrative review rather than a new surveillance dataset, but its message is pointed: horses can carry multidrug-resistant bacteria, including β-lactam-resistant organisms, even when those drugs are not heavily used in day-to-day equine practice. The authors highlight horizontal gene transfer, plasmids, and integrons as mechanisms that can accelerate dissemination of resistance genes. They also argue that gaps in treatment guidance, uneven access to evidence-based prescribing information, and inconsistent policy oversight contribute to the problem. (link.springer.com)
That framing aligns with other recent literature. A 2025 review on transmission of antimicrobial-resistant organisms between people and their dogs, cats, and horses concluded that interspecies transmission is a legitimate concern across households and veterinary settings. A 2026 Frontiers perspective also described one of the first operational U.S. models linking carbapenemase-producing Enterobacterales in companion animals and humans through whole genome sequencing, including a cluster tied to a veterinary hospital. The authors of that paper said the work exposed both the value of cross-sector surveillance and the structural barriers that still limit investigations, including testing capacity, reporting gaps, and resource constraints. (pmc.ncbi.nlm.nih.gov)
Regulators and professional groups have been moving in the same direction. CDC describes antimicrobial resistance as a One Health issue affecting people, animals, and the environment, and notes that resistant organisms can spread through contact with companion animals. FDA similarly says antimicrobial use in animals can contribute to resistance in bacteria that may be transferred to people. AVMA's stewardship principles call on veterinarians to use evidence-based prescribing, prevention, and ongoing outcome review, while WOAH has recently strengthened its standards and explicitly expanded attention to companion animals in antimicrobial use and resistance monitoring. (cdc.gov)
Why it matters: For equine and mixed-animal veterinarians, the review doesn't change policy overnight, but it does sharpen the practical implications of stewardship. Horses sit at a busy interface of clinics, barns, transport, events, and human handling, which means resistant organisms don't stay neatly confined to one patient chart. The article underscores the need for culture and susceptibility testing when feasible, tighter infection-control practices in hospitals and ambulatory settings, careful antimicrobial selection and duration, and clearer conversations with pet parents and caretakers about hygiene, wound management, manure handling, and follow-up. It also reinforces that equine medicine should be part of broader surveillance systems, not treated as a side category within companion animal AMR planning. (link.springer.com)
What to watch: The next step isn't likely to be a single regulatory event, but a slow build: more genomic surveillance, more reporting expectations, and more pressure to include horses in companion animal AMR monitoring frameworks in Europe and the U.S. WOAH's current strategy phase through 2026 includes expanding awareness and surveillance in companion animals, and recent U.S. research suggests veterinary-public health partnerships are becoming more operational. That means future studies may move beyond broad warnings and start identifying where resistance is emerging, how it's moving, and which interventions in equine practice actually reduce risk. (woah.org)